SEO URLwww.firestrike.ai/deals/cspc-pharmaceutical-group-astrazeneca-acquisition-2026-1

acquisitionAnnounced · Jan 30, 2026PharmaceuticalsSource · CredibleArticle · Factual

CSPC Pharmaceutical Group · AstraZeneca

AstraZeneca acquires CSPC Pharmaceutical Group

David Najork · Founding Software Engineer

Announced Jan 30, 2026 · Updated Apr 29, 2026 · 1 min read

ShareX LinkedIn Email

Deal value

$5B

Target

CSPC Pharmaceutical Group

Acquirer

AstraZeneca

Financial Stake

Status

Announced

AstraZeneca agreed to acquire CSPC Pharmaceutical Group. Reported deal value: $5B. Status: Announced. Sector: Pharmaceuticals. Target headquarters context: Location not specified.

This page summarizes publicly available information about the transaction as of 2026-01-30. Figures and status may change as filings and press coverage update.

8:35 PM By Andrew Silver SHANGHAI, Jan 30 – AstraZeneca will license experimental drugs for obesity and weight -related conditions from CSPC Pharmaceutical Group and collaborate on additional ‍projects, paying $1.2 billion upfront and up to $17.3 billion more if development and sales milestones are met, the Chinese drugmaker said on Friday

Deal timeline

Announced

Jan 30, 2026 · d2507.cms.socastsrm.com

Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.

Sector context

This transaction is classified in Pharmaceuticals with a reported deal value of $5B. Figures and status may change as sources update.

Sources: d2507.cms.socastsrm.com · Primary article · FireStrike proprietary index